Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,899,565
+$40,238,685 QoQ
Shares Held
2,053,960
+929.4% QoQ
Ownership
2.30%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#13
of 242 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Dec 31, 2025CallValue
$1,050,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. SNDX ranks #21 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in SNDX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,899,565 | 2,053,960 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,660,880 | 199,524 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,050,500 | 50,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $1,091,196 | 51,937 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,099,725 | 1,046,456 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,971,010 | 1,598,613 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,265,989 | 428,652 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,757,628 | 586,810 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,559,287 | 1,119,963 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,874,879 | 1,065,508 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,228,601 | 681,874 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,370,493 | 942,642 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,385,460 | 439,770 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $3,775,200 | 260,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $3,175,081 | 151,700 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $881,295 | 41,728 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $473,323 | 24,601 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,405,843 | 426,113 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $410,700 | 18,762 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $704,222 | 36,851 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,500,018 | 203,845 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $16,838,949 | 757,147 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,945,120 | 809,290 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,775,551 | 862,048 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,083,568 | 281,091 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||